Abstract
Systolic arterial hypertension is the most common variable of the hypertensive disease and it is mainly concentrated in individuals who are 60 years old and older. At a global level, such population is rapidly growing in every society.
In senior persons, losing weight and lowering sodium consumption helps decreasing Blood pressure (BP). Using antihypertensive medications reduces cardiovascular mortality. In this chapter the management of BP with diuretics is discussed.
Keywords: Arterial hypertension, blood pressure control, diuretics, elderly.
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Diuretics in the Treatment of Elderly Hypertensive Patients
Volume: 12 Issue: 3
Author(s): Cesar G. Calvo Vargas
Affiliation:
Keywords: Arterial hypertension, blood pressure control, diuretics, elderly.
Abstract: Systolic arterial hypertension is the most common variable of the hypertensive disease and it is mainly concentrated in individuals who are 60 years old and older. At a global level, such population is rapidly growing in every society.
In senior persons, losing weight and lowering sodium consumption helps decreasing Blood pressure (BP). Using antihypertensive medications reduces cardiovascular mortality. In this chapter the management of BP with diuretics is discussed.
Export Options
About this article
Cite this article as:
Calvo Vargas G. Cesar, Diuretics in the Treatment of Elderly Hypertensive Patients, Cardiovascular & Hematological Agents in Medicinal Chemistry 2014; 12 (3) . https://dx.doi.org/10.2174/1871525713666150310111250
DOI https://dx.doi.org/10.2174/1871525713666150310111250 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coronary Risk Factors in the Elderly: Their Interactions and Treatment
Current Pharmaceutical Design Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment
Reviews on Recent Clinical Trials Acute and Long-Term Effects of Cannabis Use: A Review
Current Pharmaceutical Design Stroke as a Consequence of Sleep Apnea: Epidemiology, Pathophysiology and Treatment Strategies
Current Respiratory Medicine Reviews Comparison of Amniotic Fluid Index and Single Deepest Vertical Pocket
Current Women`s Health Reviews Visit-to-visit Blood Pressure Variability and Arterial Stiffness: Which Came First: The Chicken or the Egg?
Current Pharmaceutical Design Are Catechins, Polyphenols in Tea, Good for Your Health?
Current Nutrition & Food Science Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets Pharmacology of Nitric Oxide: Molecular Mechanisms and Therapeutic Strategies
Current Pharmaceutical Design Fluid Retention and Rostral Fluid Shift in Sleep-Disordered Breathing
Current Hypertension Reviews Seeking the Active Site of the AT1 Receptor for Computational Docking Studies
Drug Design Reviews - Online (Discontinued) Thrombolysis for Acute Ischemic Stroke
Current Topics in Medicinal Chemistry Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews Treatment of Chronic Peripheral Arterial Disease
Current Vascular Pharmacology Antioxidant Therapy in Diabetic Complications: What is New?
Current Vascular Pharmacology Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Cardiac Dysfunction in Rats with Dietary-Induced Insulin Resistance Associated with Pharmacologically-induced Dyslipidemia
Current Pharmaceutical Design Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application
Current Pharmaceutical Design Mucoadhesive Microspheres Containing Anti-Hypertensive Agent: Formulation and Characterization
Current Drug Delivery The Impact of Variable Factors on the Health-Related Quality of Life in the Elderly in Japan and Russia
Current Aging Science